"Lipoxins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Trihydroxy derivatives of eicosanoic acids. They are primarily derived from arachidonic acid, however eicosapentaenoic acid derivatives also exist. Many of them are naturally occurring mediators of immune regulation.
| Descriptor ID |
D044045
|
| MeSH Number(s) |
D10.251.355.255.375
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Lipoxins".
Below are MeSH descriptors whose meaning is more specific than "Lipoxins".
This graph shows the total number of publications written about "Lipoxins" by people in this website by year, and whether "Lipoxins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 2 | 0 | 2 |
| 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Lipoxins" by people in Profiles.
-
ELV-N32 and RvD6 isomer decrease pro-inflammatory cytokines, senescence programming, ACE2 and SARS-CoV-2-spike protein RBD binding in injured cornea. Sci Rep. 2021 06 17; 11(1):12787.
-
High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients. FASEB J. 2021 06; 35(6):e21666.
-
Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm. Arch Pharm Res. 2021 Jan; 44(1):84-98.
-
Deciphering the Molecular Details of the Lipoxin Formation Mechanism in the 5(S),15(S)-DiHpETE Biosynthetic Pathway Catalyzed by Reticulocyte 15-Lipoxygenase-1. J Phys Chem B. 2020 12 17; 124(50):11406-11418.
-
Specialized proresolving mediators in infection and lung injury. Biofactors. 2021 Jan; 47(1):6-18.
-
Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection. Front Immunol. 2020; 11:1997.
-
Combating sars-cov-2 through lipoxins, proteasome, caveolin and nuclear factor-?b pathways in non-pregnant and pregnant populations. Cell Mol Biol (Noisy-le-grand). 2020 Jun 05; 66(3):221-229.
-
Modulation of microRNAs by aspirin in cardiovascular disease. Trends Cardiovasc Med. 2020 07; 30(5):249-254.
-
Dietary DHA amplifies LXA4 circuits in tissues and lymph node PMN and is protective in immune-driven dry eye disease. Mucosal Immunol. 2018 11; 11(6):1674-1683.
-
Therapeutic effect of Lipoxin A4 in malaria-induced acute lung injury. J Leukoc Biol. 2018 04; 103(4):657-670.